Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
Videos
Browse
Filter results by:

Showing: Prevention & Screening / Detection, diagnosis & prognosis

11.07.18

The iManageCancer project

11.07.18

mHealth and telemedicine apps

09.07.18

21st Century medicine is transforming healthcare and the...

09.07.18

The TAPUR trail is inspiring similar initiatives across the...

06.07.18

Biobanking and early diagnosis to defeat NSCLC

06.07.18

Patients access to precision oncology

06.07.18

Early development in oncology: Are the MTD and monotherapy...

06.07.18

U.S. National Cancer Institute perspective on precision...

06.07.18

WINTHER & SPRING: Targeted agents and triple agent...

06.07.18

MyPathway study: a novel precision oncology multiple basket...

06.07.18

Implementing precision medicine in oncology: The IMPACT...

06.07.18

Precision CAR T cell therapeutics

06.07.18

Lessons from long-term survey of stage I NSCLC

04.07.18

The latest understanding of Breakthrough Cancer Pain...

04.07.18

Editor's Choice for June 2018

03.07.18

Disease management for mCRPC

03.07.18

Advanced Prostate Cancer - The evolving landscape and...

03.07.18

Highlights from PROSCA 2018: Imaging, biomarkers and genetic...

03.07.18

Expert insight: The basic medical understanding of...

03.07.18

MASCC 2018: Chemotherapy-induced neutropenia and the role of...

27.06.18

CDK6 a transcriptional regulator in AML

24.06.18

ASCO 2018 conference round up

17.06.18

Treating CLL with obinutuzumab

17.06.18

Half of CLL patients who relapse on ibrutinib harbour...

17.06.18

Venetoclax in patients with previously treated WM

17.06.18

ICLL07 FILO study: Minimal residual disease still detectable...

17.06.18

Even late progressors with high risk factors in PRIMA...

17.06.18

Patient relevant outcomes and advocacy

17.06.18

The mutational landscape of AML

16.06.18

Lymphoma guidelines in Venezuela

16.06.18

Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma

16.06.18

EHA 2018: Research, collaboration and working towards cures

16.06.18

Educational focus on immunotherapy at EHA

16.06.18

ADC polatuzumab vedotin in combinations for relapsed...

16.06.18

iNNOVATE trial of added ibrutinib for Waldenströms...

16.06.18

EHA 2018: Initial results of the INSIGHT trial in multiple...
Last Next


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence